|
[1]
|
GBD 2019 Stroke Collaborators (2021) Global, Regional, and National Burden of Stroke and Its Risk Factors, 1990-2019: A Systematic Analysis for the Global Burden of Disease Study 2019. The Lancet Neurology, 20, 795-820.
|
|
[2]
|
Zhou, Y., Han, W., Gong, D., Man, C. and Fan, Y. (2016) Hs-CRP in Stroke: A Meta-Analysis. Clinica Chimica Acta, 453, 21-27. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Buck, B.H., Liebeskind, D.S., Saver, J.L., Bang, O.Y., Yun, S.W., Starkman, S., et al. (2008) Early Neutrophilia Is Associated with Volume of Ischemic Tissue in Acute Stroke. Stroke, 39, 355-360. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Kuo, H., Yen, C., Chang, C., Kuo, C., Chen, J. and Sorond, F. (2005) Relation of C-Reactive Protein to Stroke, Cognitive Disorders, and Depression in the General Population: Systematic Review and Meta-Analysis. The Lancet Neurology, 4, 371-380. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Di Napoli, M., Papa, F. and Bocola, V. (2001) Prognostic Influence of Increased C-Reactive Protein and Fibrinogen Levels in Ischemic Stroke. Stroke, 32, 133-138. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Elkind, M.S.V., Luna, J.M., McClure, L.A., Zhang, Y., Coffey, C.S., Roldan, A., et al. (2014) C-Reactive Protein as a Prognostic Marker after Lacunar Stroke: Levels of Inflammatory Markers in the Treatment of Stroke Study. Stroke, 45, 707-716. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Alessandro, O., Rene, W., Stefan, W., Miodrag, F., Martin, S., Oliver, B., et al. (2022) C-Reactive Protein Elevation Predicts In-Hospital Deterioration after Aneurysmal Subarachnoid Hemorrhage: A Retrospective Observational Study. Acta Neurochirurgica, 164, 1805-1814. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Andoh, M. and Koyama, R. (2021) Comparative Review of Microglia and Monocytes in CNS Phagocytosis. Cells, 10, Article 2555. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Boehme, A.K., Kumar, A.D., Lyerly, M.J., Gillette, M.A., Siegler, J.E., Albright, K.C., et al. (2014) Persistent Leukocytosis—Is This a Persistent Problem for Patients with Acute Ischemic Stroke? Journal of Stroke and Cerebrovascular Diseases, 23, 1939-1943. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Christensen, H. and Boysen, G. (2004) C-reactive Protein and White Blood Cell Count Increases in the First 24 Hours after Acute Stroke. Cerebrovascular Diseases, 18, 214-219. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Furlan, J.C., Vergouwen, M.D.I., Fang, J. and Silver, F.L. (2013) White Blood Cell Count Is an Independent Predictor of Outcomes after Acute Ischaemic Stroke. European Journal of Neurology, 21, 215-222. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Elkind, M.S.V., Cheng, J., Rundek, T., Boden-Albala, B. and Sacco, R.L. (2004) Leukocyte Count Predicts Outcome after Ischemic Stroke: The Northern Manhattan Stroke Study. Journal of Stroke and Cerebrovascular Diseases, 13, 220-227. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Sansanayudh, N., Muntham, D., Yamwong, S., McEvoy, M., Attia, J., Sritara, P., et al. (2015) Prognostic Effect of Mean Platelet Volume in Patients with Coronary Artery Disease. A Systematic Review and Meta-Analysis. Thrombosis and Haemostasis, 114, 1299-1309. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Woodward, M., Barzi, F., Feigin, V., Gu, D., Huxley, R., Nakamura, K., et al. (2007) Associations between High-Density Lipoprotein Cholesterol and Both Stroke and Coronary Heart Disease in the Asia Pacific Region. European Heart Journal, 28, 2653-2660. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Sever, P.S., Dahlöf, B., Poulter, N.R., Wedel, H., Beevers, G., Caulfield, M., et al. (2004) Prevention of Coronary and Stroke Events with Atorvastatin in Hypertensive Patients Who Have Average or Lower-Than-Average Cholesterol Concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA). Drugs, 64, 43-60. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Rist, P.M., Buring, J.E., Ridker, P.M., Kase, C.S., Kurth, T. and Rexrode, K.M. (2019) Lipid Levels and the Risk of Hemorrhagic Stroke among Women. Neurology, 92, e2286-e2294. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Ma, C., Gurol, M.E., Huang, Z., Lichtenstein, A.H., Wang, X., Wang, Y., et al. (2019) Low-Density Lipoprotein Cholesterol and Risk of Intracerebral Hemorrhage. Neurology, 93, e445-e457. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Wu, Z., Huang, Z., Lichtenstein, A.H., Liu, Y., Chen, S., Jin, Y., et al. (2021) The Risk of Ischemic Stroke and Hemorrhagic Stroke in Chinese Adults with Low-Density Lipoprotein Cholesterol Concentrations < 70 mg/dL. BMC Medicine, 19, Article No. 142. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Navab, M., Anantharamaiah, G.M., Reddy, S.T., Van Lenten, B.J. and Fogelman, A.M. (2009) HDL as a Biomarker, Potential Therapeutic Target, and Therapy. Diabetes, 58, 2711-2717. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Rohatgi, A., Khera, A., Berry, J.D., Givens, E.G., Ayers, C.R., Wedin, K.E., et al. (2014) HDL Cholesterol Efflux Capacity and Incident Cardiovascular Events. New England Journal of Medicine, 371, 2383-2393. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Desforges, J.F., Gordon, D.J. and Rifkind, B.M. (1989) High-Density Lipoprotein—The Clinical Implications of Recent Studies. New England Journal of Medicine, 321, 1311-1316. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
van der Stoep, M., Korporaal, S.J.A. and Van Eck, M. (2014) High-Density Lipoprotein as a Modulator of Platelet and Coagulation Responses. Cardiovascular Research, 103, 362-371. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Calkin, A.C., Drew, B.G., Ono, A., Duffy, S.J., Gordon, M.V., Schoenwaelder, S.M., et al. (2009) Reconstituted High-Density Lipoprotein Attenuates Platelet Function in Individuals with Type 2 Diabetes Mellitus by Promoting Cholesterol Efflux. Circulation, 120, 2095-2104. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Kelly, D.M., Ademi, Z., Doehner, W., Lip, G.Y.H., Mark, P., Toyoda, K., et al. (2021) Chronic Kidney Disease and Cerebrovascular Disease: Consensus and Guidance from a KDIGO Controversies Conference. Stroke, 52, e328-e346. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Weng, Z., Huang, X., Deng, D., Yang, Z., Li, S., Zang, J., et al. (2022) A New Nomogram for Predicting the Risk of Intracranial Hemorrhage in Acute Ischemic Stroke Patients after Intravenous Thrombolysis. Frontiers in Neurology, 13, Article 774654. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Lee, M., Saver, J.L., Chang, K., Liao, H., Chang, S. and Ovbiagele, B. (2010) Low Glomerular Filtration Rate and Risk of Stroke: Meta-Analysis. BMJ, 341, c4249-c4249. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
Johnston, K.C., Hall, C.E., Kissela, B.M., Bleck, T.P. and Conaway, M.R. (2009) Glucose Regulation in Acute Stroke Patients (GRASP) Trial. Stroke, 40, 3804-3809. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Johnston, K.C., Bruno, A., Pauls, Q., Hall, C.E., Barrett, K.M., Barsan, W., et al. (2019) Intensive vs Standard Treatment of Hyperglycemia and Functional Outcome in Patients with Acute Ischemic Stroke: The SHINE Randomized Clinical Trial. JAMA, 322, 326-335. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
Park, C.R. (2001) Cognitive Effects of Insulin in the Central Nervous System. Neuroscience & Biobehavioral Reviews, 25, 311-323. [Google Scholar] [CrossRef] [PubMed]
|
|
[30]
|
Jiang, Z., Wang, K., Duan, H., Du, H., Gao, S., Chen, J., et al. (2024) Association between Stress Hyperglycemia Ratio and Prognosis in Acute Ischemic Stroke: A Systematic Review and Meta-Analysis. BMC Neurology, 24, Article No. 13. [Google Scholar] [CrossRef] [PubMed]
|